Biogen Inc.

Contributing Author

Recent Articles by Biogen Inc.

Jun-18	Biogen Initiates Phase 3 Pediatric Study of Omaveloxolone for the Treatment of Friedreich Ataxia BIIB GlobeNewswire
Jun-12	Dapirolizumab Pegol Phase 3 Data in SLE Presented at the Annual European Congress of Rheumatology (EULAR) Show Improvement in Fatigue and Reduction in Disease Activity BIIB GlobeNewswire
May-27	Biogen and City Therapeutics Announce Strategic Research Collaboration to Develop Select Novel RNAi-based Therapies BIIB GlobeNewswire